Chris Williams
Fortune : 41 729 $ au 31/07/2026
Fortune : 41 729 $ au 31/07/2026
Chris Williams is Chief Business Development Officer & Senior VP at Autolus Therapeutics Plc since 2024.
Former roles include Non-Executive Director at Autolus Ltd. and Director at Orchard Therapeutics (Europe) Ltd. Education includes graduate studies at Imperial College London and undergraduate studies at the University of Cardiff.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AUTOLUS THERAPEUTICS PLC 0,02 % | 18/03/2026 | 28 006 ( 0,02 % ) | 41 729 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Corporate Officer/Principal | 01/02/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Directeur/Membre du Conseil | - |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cardiff
University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national